4basebio PLC (AIM:4BB)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 530.00
0.00 (0.00%)
Nov 4, 2026, 8:00 AM GMT
4basebio Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.78 | 1.69 | 0.93 | 0.51 | 0.27 | 0.34 | |
Revenue Growth | -56.10% | 81.46% | 84.39% | 88.81% | -20.71% | -26.84% |
Cost of Revenue | 0.37 | 0.72 | 0.3 | 0.17 | 0.03 | 0.07 |
Gross Profit | 0.41 | 0.97 | 0.63 | 0.34 | 0.24 | 0.27 |
Selling, General & Admin | 17.81 | 17.7 | 13.87 | 8.81 | 3.88 | 1.86 |
Research & Development | - | - | - | - | 2.08 | 1.62 |
Other Operating Expenses | -0.24 | -0.06 | -0.44 | -0.31 | -0.06 | 0.32 |
Operating Expenses | 17.6 | 17.64 | 13.42 | 8.51 | 5.91 | 3.8 |
Operating Income | -17.2 | -16.66 | -12.79 | -8.17 | -5.67 | -3.53 |
Interest Expense | -0.96 | -0.89 | -0.75 | -0.3 | -0.09 | -0.11 |
Interest & Investment Income | 0.51 | 0.88 | 0.14 | - | - | - |
Currency Exchange Gain (Loss) | -0.94 | -0.94 | 0.75 | 0.11 | -0.17 | - |
EBT Excluding Unusual Items | -18.58 | -17.6 | -12.65 | -8.35 | -5.93 | -3.64 |
Pretax Income | -18.58 | -17.6 | -12.65 | -8.35 | -5.93 | -3.64 |
Income Tax Expense | -0.55 | -0.7 | -0.32 | -0.69 | -0.78 | -0.41 |
Net Income | -18.03 | -16.91 | -12.33 | -7.67 | -5.15 | -3.24 |
Net Income to Common | -18.03 | -16.91 | -12.33 | -7.67 | -5.15 | -3.24 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 16 | 16 | 13 | 12 | 12 | 12 |
Shares Outstanding (Diluted) | 16 | 16 | 13 | 12 | 12 | 12 |
Shares Change | 7.11% | 18.26% | 6.47% | 0.01% | - | 37.05% |
EPS (Basic) | -1.16 | -1.09 | -0.94 | -0.62 | -0.42 | -0.26 |
EPS (Diluted) | -1.16 | -1.09 | -0.94 | -0.62 | -0.42 | -0.26 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -17.06 | -16.06 | -11.44 | -7.05 | -5.86 | -3.62 |
Free Cash Flow Per Share | -1.10 | -1.03 | -0.87 | -0.57 | -0.48 | -0.29 |
Gross Margin | 52.11% | 57.53% | 67.52% | 67.19% | 89.18% | 79.59% |
Operating Margin | -2201.92% | -984.29% | -1371.17% | -1613.83% | -2115.30% | -1043.49% |
Profit Margin | -2307.94% | -998.52% | -1321.87% | -1514.82% | -1921.64% | -957.10% |
Free Cash Flow Margin | -2184.76% | -948.49% | -1226.26% | -1393.08% | -2186.19% | -1072.19% |
EBITDA | -16.3 | -15.75 | -12.04 | -7.6 | -5.33 | -3.35 |
D&A For EBITDA | 0.9 | 0.92 | 0.76 | 0.57 | 0.34 | 0.18 |
EBIT | -17.2 | -16.66 | -12.79 | -8.17 | -5.67 | -3.53 |